Project

COGEVAB: New COmputational tools at the molecular scale for studying effects of GEnetic VAriants on drug Binding

Acronym
COGEVAB
Code
3G017920
Duration
01 January 2020 → 31 December 2023
Funding
Research Foundation - Flanders (FWO)
Promotor
Research disciplines
  • Natural sciences
    • Statistical physics
    • Soft condensed matter
    • Theoretical and computational chemistry not elsewhere classified
    • Computational biomodelling and machine learning
Keywords
computational biophysics molecular modeling binding site search algorithm
 
Project description

Protein binding sites are functionally important regions on protein surfaces, through which proteins interact with other molecules, such as drugs Sequence variants are variations in a single nucleotide that occur at a specific position in the genome and can alter proteins, sometimes resulting in dysfunctional proteins causing various diseases and changing individual's response to drugs This proposal will focus on the development and use of computational methods at the molecular scale for precision medicine to detect binding sites and to map sequence variants to binding sites With such new approaches we will investigate how sequence variants change properties of binding sites

Further, our aim is to include protein flexibility to improve the scoring of the binding affinity by using enhanced molecular dynamics simulations This will be aided by vibrational modes to define the essential coordinates of the binding site movements To disseminate our methods and reach higher impact, special emphasis will be given to sharing the newly developed computational methods with the community by making them easily accessible through a web-based interface and server The proposed project's contribution will be a new computational tool for precision medicine, enabling prediction of changes in drug binding due to sequence variants Discovery of these sequence variants is important and will have wide implications for research and generation of new hypotheses in medicine and drug discovery